NexgenRx Inc. (TSXV:NXG)

NexgenRx Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.78	1.71	1.88	1.77	2.32
Cash & Short-Term Investments	4.78	1.71	1.88	1.77	2.32
Cash Growth	180.05%	-9.12%	6.22%	-23.74%	188.92%
Accounts Receivable	0.73	0.82	0.73	0.41	0.48
Other Receivables	-	0.05	0.05	-	-
Total Trade Receivables	0.73	0.87	0.78	0.41	0.48
Other Current Assets	26.9	22.07	20.69	15.83	18.03
Total Current Assets	32.4	24.65	23.34	18	20.83
Net Property, Plant & Equipment	0.8	0.83	0.81	0.84	0.5
Other Intangible Assets	1.4	2.33	3.15	4.1	5.12
Goodwill	1.08	1.24	1.24	1.24	1.24
Long-Term Investments	0.37	0.18	-	-	-
Other Long-Term Assets	0.56	1.24	1.66	1.57	1.74
Total Assets	36.6	30.46	30.2	25.75	29.44
Accounts Payable	1.98	0.5	1.18	0.92	1.41
Current Portion of Leases	0.08	0.11	0.06	0.04	0.23
Other Current Liabilities	26.63	21.8	20.84	15.54	17.91
Total Current Liabilities	28.69	22.41	22.08	16.51	19.55
Long-Term Leases	0.29	0.43	0.4	0.39	0.17
Total Long-Term Liabilities	0.29	0.43	0.4	0.39	0.17
Total Liabilities	28.98	22.84	22.48	16.9	19.72
Preferred Stock	1.65	1.65	1.65	1.65	1.65
Common Stock	4.01	4.01	3.82	19.29	19.29
Additional Paid-in Capital	4.4	4.39	4.38	4.35	4.3
Retained Earnings	-2.44	-2.43	-2.14	-16.43	-15.53
Shareholders' Equity	7.62	7.62	7.71	8.85	9.71
Total Liabilities & Equity	36.6	30.46	30.2	25.75	29.44
Total Debt	0.37	0.53	0.46	0.43	0.4
Net Cash (Debt)	4.41	1.17	1.41	1.33	1.92
Net Cash Growth	276.44%	-17.18%	6.03%	-30.33%	-
Net Cash Per Share	0.06	0.01	0.02	0.02	0.03
Book Value	7.62	7.62	7.71	8.85	9.71
Book Value Per Share	0.10	0.10	0.11	0.13	0.13
Tangible Book Value	5.14	4.06	3.33	3.51	3.36
Tangible Book Value Per Share	0.07	0.05	0.05	0.05	0.04

Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.